Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Est. Listeners
Based on iTunes & Spotify (publisher stats).
- Per-Episode Audience
Est. listeners per new episode within ~30 days
10,001 - 25,000 - Monthly Reach
Unique listeners across all episodes (30 days)
25,001 - 75,000 - Active Followers
Loyal subscribers who consistently listen
15,001 - 40,000
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 10 epsHosts
Recent guests
Recent episodes
Localized Bladder Cancer 2026 UPDATE
Apr 27, 2026
13m 21s
4 Years with Two Onc Docs
Apr 20, 2026
12m 00s
Pancreatic Cancer x Dr. Michael Pishvaian 2026 UPDATE Part 3
Apr 13, 2026
14m 01s
Metastatic Pancreatic Cancer x Dr. Michael Pishvaian 2026 UPDATE Part 2
Apr 6, 2026
25m 07s
Localized Pancreatic Cancer x Dr. Michael Pishvaian 2026 UPDATE Part 1
Mar 30, 2026
37m 00s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 4/27/26 | Localized Bladder Cancer 2026 UPDATE✨ | bladder cancerpathology+3 | — | localized bladder cancer | 2026 | bladder cancerlocalized cancer+5 | — | 13m 21s | |
| 4/20/26 | 4 Years with Two Onc Docs✨ | anniversarypodcast future+3 | — | Two Onc DocsBladder Cancer | — | Two Onc Docshematology+3 | — | 12m 00s | |
| 4/13/26 | Pancreatic Cancer x Dr. Michael Pishvaian 2026 UPDATE Part 3✨ | pancreatic cancersupportive care+3 | Dr. Michael Pishvaian | Johns Hopkins Kimmel Cancer CenterTumor Board Tuesday | — | pancreatic cancersupportive care+3 | — | 14m 01s | |
| 4/6/26 | Metastatic Pancreatic Cancer x Dr. Michael Pishvaian 2026 UPDATE Part 2✨ | metastatic pancreatic cancer1L treatments+3 | Dr. Michael Pishvaian | Johns Hopkins Kimmel Cancer CenterTumor Board Tuesday | — | metastatic pancreatic cancer1L treatments+3 | — | 25m 07s | |
| 3/30/26 | Localized Pancreatic Cancer x Dr. Michael Pishvaian 2026 UPDATE Part 1✨ | Pancreatic Cancerrisk factors+3 | Dr. Michael Pishvaian | Johns Hopkins Kimmel Cancer CenterTumor Board Tuesday | — | localized pancreatic cancerrisk factors+3 | — | 37m 00s | |
| 3/23/26 | ASCO GU 2026 Takeaways✨ | ASCO GUprostate cancer+3 | — | ASCO GU | San Francisco | ASCO GUprostate cancer+5 | — | 12m 09s | |
| 3/16/26 | Neuroendocrine Tumors 2026 UPDATE✨ | Neuroendocrine Tumorsdiagnosis+3 | — | Neuroendocrine Tumorsgastro-entero-pancreatic NETs | — | Neuroendocrine TumorsNET+3 | — | 23m 35s | |
| 3/9/26 | Venous Thromboembolism (VTE) in Cancer Part 2✨ | Venous ThromboembolismCancer+5 | Dr. Marc Carrier | — | — | VTEcancer+6 | — | 14m 24s | |
| 3/2/26 | Venous Thromboembolism (VTE) in Cancer Part 1✨ | Venous ThromboembolismCancer+3 | Dr. Marc Carrier | University of Ottawa | — | VTEcancer+3 | — | 12m 05s | |
| 2/24/26 | ASCO GU 2026 Preview✨ | ASCO GUcancer research+4 | — | ASCOprostate cancer+3 | San Francisco | ASCO GUcancer+6 | — | 11m 35s |
Showing 10 of 10
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
3 placements across 3 markets.
Chart Positions
3 placements across 3 markets.